Skip to main content

Table 1 Effect of POLY-CSNPs, POLY, and METF on urea, creatinine, uric acid, MDA, GSH, SOD, POX, CAT, Nrf2, and HO-1 in the studied groups

From: Polydatin nanoparticles attenuate oxidative stress and histopathological changes in streptozotocin model of diabetic nephropathy: targeting Nrf2/HO-1/NF-κβ signaling pathways

Tests

Groups

C

D

D + CSNPs

D + POLY-CSNPs

D + POLY

D + METF

Urea

(mg/dl)

31.730 ± 4.006

64.366 ± 2.501###

61.785 ± 0.825

26.092 ± 1.259***

34.633 ± 0.661***

28.735 ± 0.228***

Creatinine

(mg/dl)

1.857 ± 0.163

3.692 ± 0.246###

3.618 ± 0.312

1.876 ± 0.087***

2.025 ± 0.062***

1.975 ± 0.136***

Uric acid

(mg/dl)

2.889 ± 0.048

4.320 ± 0.044###

4.523 ± 0.102

2.699 ± 0.114***

2.924 ± 0.094***

2.889 ± 0.123***

MDA

(nmol/g protein)

208.667 ± 34.296

452.539 ± 19.257###

485.560 ± 24.157

246.695 ± 34.996***

314.156 ± 15.748*

275.290 ± 24.526**

GSH

(nmol/mg protein)

13.060 ± 0.685

6.562 ± 0.174###

6.739 ± 0.458

13.170 ± 0.779***

10.926 ± 0.501**

12.141 ± 1.447***

SOD activity

(U/g protein)

1.194 ± 0.094

0.643 ± 0.041###

0.645 ± 0.051

1.179 ± 0.080***

1.026 ± 0.061**

1.130 ± 0.045***

POX activity (U/g protein)

1.084 ± 0.048

0.571 ± 0.055###

0.586 ± 0.055

1.059 ± 0.126***

0.908 ± 0.026*

0.924 ± 0.017 **

Catalase activity (U/g protein)

0.576 ± 0.056

0.130 ± 0.041###

0.175 ± 0.031

0.647 ± 0.064***

0.551 ± 0.057***

0.573 ± 0.036***

Nrf2

(Relative to control)

1.010 ± 0.004

0.353 ± 0.014###

0.303 ± 0.021

0.827 ± 0.037***

0.600 ± 0.027**

0.748 ± 0.018***

HO-1

(Relative to control)

1.510 ± 0.153

0.520 ± 0.042###

0.587 ± 0.018

1.057 ± 0.046***

0.823 ± 0.015*

0.917 ± 0.031**

  1. Data are expressed as mean ± SEM (n = 6). C: control rats; D: diabetic rats; D + CSNPs: diabetic rats treated with blank chitosan nanoparticles; D + POLY-CSNPs: diabetic rats treated with polydatin-loaded chitosan nanoparticles; D + POLY: diabetic rats treated with polydatin; D + METF: diabetic rats treated with metformin HCl; MDA: lipid peroxidation; GSH: reduced glutathione concentration; SOD: superoxide dismutase activity; POX: peroxidase activity; CAT: catalase activity; Nrf2: nuclear factor erythroid 2-related factor 2; HO-1: heme oxygenase-1. ###P < 0.001 versus control; *P < 0.05, **P < 0.01 and ***P < 0.001 versus diabetic control